These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6386187)

  • 1. Growth inhibition of Cryptococcus neoformans by cloned cultured murine macrophages.
    Kitz DJ; Johnson CR; Kobayashi GS; Medoff G; Little JR
    Cell Immunol; 1984 Oct; 88(2):489-500. PubMed ID: 6386187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
    Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
    Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
    Mukherjee S; Lee SC; Casadevall A
    Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
    Cross CE; Collins HL; Bancroft GJ
    Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.
    Kelly RM; Chen J; Yauch LE; Levitz SM
    Infect Immun; 2005 Jan; 73(1):592-8. PubMed ID: 15618199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.
    Collins HL; Bancroft GJ
    Eur J Immunol; 1992 Jun; 22(6):1447-54. PubMed ID: 1601035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-mediated fungistasis: requirement for a macromolecular component in serum.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jul; 137(2):693-701. PubMed ID: 3522734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages.
    Weinberg PB; Becker S; Granger DL; Koren HS
    Am Rev Respir Dis; 1987 Nov; 136(5):1242-7. PubMed ID: 3314617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
    Levitz SM; Farrell TP
    Infect Immun; 1990 May; 58(5):1201-9. PubMed ID: 2182538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins.
    Mukherjee S; Feldmesser M; Casadevall A
    J Infect Dis; 1996 May; 173(5):1222-31. PubMed ID: 8627076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsular specific IgM enhances complement-mediated phagocytosis and killing of Cryptococcus neoformans by methamphetamine-treated J774.16 macrophage-like cells.
    Aslanyan L; Ekhar VV; DeLeon-Rodriguez CM; Martinez LR
    Int Immunopharmacol; 2017 Aug; 49():77-84. PubMed ID: 28551495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
    Cross CE; Bancroft GJ
    Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.
    Griffin FM
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3853-7. PubMed ID: 7022456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
    Kozel TR; Follette JL
    Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide.
    Kawakami K; Zhang T; Qureshi MH; Saito A
    Cell Immunol; 1997 Aug; 180(1):47-54. PubMed ID: 9316638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.